Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis)
暂无分享,去创建一个
D. Gaya | S. Sebastian | P. Hamlin | C. Probert | P. Irving | H. Tate | G. Gillespie | Anita Rose | C. Wheeler